XML 153 R130.htm IDEA: XBRL DOCUMENT
v3.23.1

Liabilities for puttable financial instrument - Additional Information (Details) - ACT Genomics Holdings Company Limited [Member] | Dec. 30, 2022
--- | ---
Disclosure of reconciliation of liabilities arising from puttable financial instrument [Line Items] |
Percentage of equity interest acquired | 74.39%
Puttable, Bond Granted [Member] |
Disclosure of reconciliation of liabilities arising from puttable financial instrument [Line Items] |
Percentage of equity interest acquired | 74.39%

X
- Definition The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2022-03-24 -Paragraph B64 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B -URIDate 2022-03-24 + Details
Name: | ifrs-full_PercentageOfVotingEquityInterestsAcquired
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Disclosure of reconciliation of liabilities arising from puttable financial instrument. + References No definition available. + Details
Name: | pre_DisclosureOfReconciliationOfLiabilitiesArisingFromPuttableFinancialInstrumentLineItems
Namespace Prefix: | pre_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=pre_ActGenomicsHoldingsCompanyLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | pre_TypesOfOptionsToIssuersEquityAxis=pre_PuttableBondGrantedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |